Bis(2-methoxyethyl)aminosulfur trifluoride: a new broad-spectrum deoxofluorinating agent with enhanced thermal stability
作者:Gauri S. Lal、Guido P. Pez、Reno J. Pesaresi、Frank M. Prozonic
DOI:10.1039/a808517j
日期:——
Bis(2-methoxyethyl)aminosulfur trifluoride (Deoxo-FluorTM) is effective for the conversion of alcohols to alkyl fluorides, aldehydes/ketones to the corresponding gem-difluorides and also for the transformation of carboxylic acids to their trifluoromethyl derivatives; it is a less thermally sensitive, broader-spectrum alternative to the traditional dialkylaminosulfur trifluoride (DAST) deoxofluorination reagents.
PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF ISOMER FREE PROSTAGLANDINS
申请人:CHIROGATE INTERNATIONAL INC.
公开号:US20180050999A1
公开(公告)日:2018-02-22
Novel processes for the preparation of a compound of Formula I-2 substantially free of the 5,6-trans isomer:
wherein
R
2
, R
3
and R
4
are as defined in the specification are provided. Novel intermediates for the preparations of isomer free Prostaglandins and derivatives thereof are also provided.
Bis(2-methoxyethyl)aminosulfur Trifluoride: A New Broad-Spectrum Deoxofluorinating Agent with Enhanced Thermal Stability
作者:Gauri S. Lal、Guido P. Pez、Reno J. Pesaresi、Frank M. Prozonic、Hansong Cheng
DOI:10.1021/jo990566+
日期:1999.9.1
Bis(2-methoxyethyl)aminosulfur trifluoride, (CH3OCH2CH2)(2)NSF3 (Deoxo-Fluor reagent), is a new deoxofluorinating agent that is much more thermally stable than DAST (C2H5)(2)NSF3 and its congeners. It is effective for the conversion of alcohols to alkyl fluorides, aldehydes/ketones to the corresponding gem-difluorides, and carboxylic acids to the trifluoromethyl derivatives with, in some cases, superior performance compared to DAST. The enhanced stability is rationalized on the basis of conformational rigidity imposed by a coordination of the alkoxy groups with the electron-deficient sulfur atom of the trifluoride.
THIOPHENE DERIVATIVES USEFUL AS MEDICAMENTS FOR TREATING OCULAR HYPERTENSION
申请人:ALLERGAN, INC.
公开号:EP2125773B1
公开(公告)日:2011-01-26
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS
申请人:Graybug Vision,Inc.
公开号:US20180036416A1
公开(公告)日:2018-02-08
The disclosure describes prodrugs and derivatives of prostaglandins, carbonic anhydrase inhibitors, kinase inhibitors, beta-adrenergic receptor antagonists and other drugs, as well as controlled delivery formulations containing such prodrugs and derivatives, for the treatment of ocular disorders.